Positron Emission Tomography (PET) Imaging of Thrombosis

Recruiting now · Phase 1

Conditions studied: Atrial Fibrillation, COVID-19, Cancer, Thrombosis

In brief

The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasive alternative to the current standard-of-care methods.

Key facts

Study ID

NCT03830320

Run by

Massachusetts General Hospital

People needed

165

Starts

2016-04-01

Expected to finish

2027-01-31

Last updated by the study team

2026-02-27

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.